(3AS,8aR)-2-(4-methoxy-6-methylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole

Catalog No. :
ACKABX324
CAS No. :
2757082-41-8
Molecular Formula :
C17H16N2O2
Molecular Weight :
280.33

IUPAC Name:(3aS,8aR)-2-(4-methoxy-6-methylpyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole

(3AS,8aR)-2-(4-methoxy-6-methylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$128.00Login to see priceInquiryInquiry
250mg98%$215.00Login to see priceInquiryInquiry
1g98%$582.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3AS,8aR)-2-(4-methoxy-6-methylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole
IUPAC Name(3aS,8aR)-2-(4-methoxy-6-methylpyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole
Molecular FormulaC17H16N2O2
Molecular Weight280.33
SMILESCOC1=CC(C2=N[C@H]3C4=C(C=CC=C4)C[C@H]3O2)=NC(C)=C1
InChI KeyZCNSMCDTCMFWNH-CVEARBPZSA-N
Synonym8H-Indeno[1,2-d]oxazole, 3a,8a-dihydro-2-(4-methoxy-6-methyl-2-pyridinyl)-, (3aS,8aR)-
CAS No.2757082-41-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACKABX324 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKABX324 route product structure diagram
    ACKABX3242757082-41-8
Inquiry

2. ACKABX324 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKABX324 route product structure diagram
    ACKABX3242757082-41-8
Inquiry

Comments (0)